Asimadoline hydrochloride
98%
- Product Code: 55453
Alias:
Related CAS: 153205-46-0
CAS:
185951-07-9
| Molecular Weight: | 451.01 g./mol | Molecular Formula: | C₂₇H₃₁ClN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Asimadoline hydrochloride is primarily used in medical research and clinical applications due to its role as a selective kappa opioid receptor agonist. It is investigated for its potential in managing irritable bowel syndrome (IBS) by reducing visceral pain and discomfort associated with the condition. The compound has shown promise in alleviating symptoms like abdominal pain and bloating without the side effects commonly linked to traditional opioid medications. Additionally, it is being studied for its potential in treating other gastrointestinal disorders and chronic pain conditions, offering a targeted approach to pain management with minimal systemic effects. Its application in clinical trials continues to explore its efficacy and safety in various therapeutic contexts.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | €131.38 |
+
-
|
| 0.005 | 10-20 days | €250.10 |
+
-
|
| 0.025 | 10-20 days | €1,018.35 |
+
-
|
Asimadoline hydrochloride
Asimadoline hydrochloride is primarily used in medical research and clinical applications due to its role as a selective kappa opioid receptor agonist. It is investigated for its potential in managing irritable bowel syndrome (IBS) by reducing visceral pain and discomfort associated with the condition. The compound has shown promise in alleviating symptoms like abdominal pain and bloating without the side effects commonly linked to traditional opioid medications. Additionally, it is being studied for its potential in treating other gastrointestinal disorders and chronic pain conditions, offering a targeted approach to pain management with minimal systemic effects. Its application in clinical trials continues to explore its efficacy and safety in various therapeutic contexts.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :